Source: MarketScreener

Trilogy Automotive: JenaValve Announces First European Commercial Implants with the Trilogy Heart Valve System

(marketscreener.com) IRVINE, Calif., Oct. 18, 2021 -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement systems, today announced the first commercial implants with the Trilogy Heart Valve System in Europe. The procedures, which included treatment of both aortic regurgitation1 and aortic...https://www.marketscreener.com/news/latest/JenaValve-Announces-First-European-Commercial-Implants-with-the-Trilogy-trade-Heart-Valve-System--36711105/?utm_medium=RSS&utm_content=20211018

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Joe Liemandt's photo - CEO of Trilogy

CEO

Joe Liemandt

CEO Approval Rating

82/100

Read more